Keyphrases
Multiple Myeloma
100%
CD138
66%
Syngeneic Model
66%
ImmunoPET
66%
COVID-19
66%
Immuno-positron Emission Tomography
55%
18F-fluorodeoxyglucose (18F-FDG)
53%
Sarbecovirus
41%
Neutralizing Nanobody
33%
Desferrioxamine
33%
Polycistronic mRNA
33%
64CuCl2
33%
Antigenic Drift
33%
Ribosome Display
33%
SARS-CoV-1
33%
Pattern Control
33%
Broadly Neutralizing
33%
Affitin
33%
Affinity Protein
33%
Binder
33%
Methylation Pattern
33%
Lineage-specific
33%
Positron Emission Tomography
33%
PET Imaging
33%
Melanoma
33%
Nanobody
33%
Radionuclides
33%
Melanoma Antigens
33%
Memory B Cells
33%
SARS-CoV-2 Infection
33%
CDR Regions
33%
Combinatorial Library
25%
Amino Acids
25%
Melanocytic Nevus
25%
Myeloma Cells
22%
Multiple Myeloma Patients
22%
Tumor
20%
Bone Lesions
18%
Subcutaneous Tumor
18%
Affinity Ligands
16%
Acidianus
16%
Engineered Protein
16%
Sul7d
16%
Sso7d
16%
SARS-CoV-2 Receptor Binding Domain
16%
Sac7d
16%
MELOE-1
16%
Archaeal
16%
SARS-CoV-2 Antigen
16%
Protein Family
16%
Medicine and Dentistry
Multiple Myeloma
100%
Immunoglobulin
77%
Positron Emission Tomography
77%
Neoplasm
52%
Copper 64
50%
Polyethylene Terephthalate
38%
Fluorodeoxyglucose F 18
37%
Methylation
33%
Melanoma Antigen
33%
Radioisotope
33%
Melanoma
33%
Messenger RNA
33%
Deferoxamine
20%
Promoter Region
20%
Radiopharmaceutical Agent
17%
Biodistribution
17%
Myeloma Cell
14%
Demethylation
13%
Melanocyte
13%
Bone Lesion
13%
Biological Marker
11%
Monoclonal Antibody
11%
Tumor Imaging
8%
Radioactive Tracer
8%
Zirconium 89
8%
Cell Culture
6%
CpG Island
6%
Mesothelioma Cell Line
6%
Blood Group A Antigen
6%
Epigenetic Mechanism
6%
Immunotherapy
6%
Pyrosequencing
6%
Bisulfite
6%
Colon
6%
Colon Cancer Cell Line
6%
Cell Lineage
6%
Immune Checkpoint Inhibitor
5%
Disease
5%
Imaging Agent
5%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Immunoglobulin
77%
Neoplasm
58%
Copper 64
50%
Fluorodeoxyglucose F 18
40%
Polyethylene Terephthalate
38%
Deferoxamine
33%
Radioisotope
33%
Radiopharmaceutical Agent
20%
Biodistribution
20%
Bone Lesion
16%
Zirconium 89
13%
Biological Marker
11%
Monoclonal Antibody
11%
Mouse Model
10%
Murine
10%
Myeloma
10%
Tracer
10%
Benzyl Isothiocyanate
6%
Chelating Agent
6%
Disease
5%
Immune Checkpoint Inhibitor
5%
